Alpha Tau Medical Ltd. - Ordinary Shares (NQ: DRTS )
3.050 UNCHANGED Streaming Delayed Price Updated: 3:59 PM EDT, Sep 26, 2023 Add to My Watchlist
All News about Alpha Tau Medical Ltd. - Ordinary Shares
Sidoti Events, LLC's Virtual June Small-Cap Conference
June 13, 2023
Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University
May 17, 2023
-First patient treated in the feasibility and safety study of intratumoral diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of new and recurrent squamous cell carcinoma of the...
Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial
April 03, 2023
First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of advanced inoperable pancreatic cancer.
Alpha Tau to Present at Upcoming November Investor Conferences
November 09, 2022